Table 2.
Author | Year | Procedure | Number of <20 mm | Number of ≥20 mm | Diagnostic Rate of <20 mm | Diagnostic Rate of ≥20 mm | Adverse Event (%) |
---|---|---|---|---|---|---|---|
Ihara et al. [68] | 2013 | MIAB | 15 | 12 | 0.80 | 0.92 | 0 |
Osoegawa et al. [56] | 2019 | MIAB | 11 | 12 | 0.91 | 0.92 | 0 |
Minoda et al. [58] | 2020 | MIAB | 45 | 26 | 0.93 | 0.92 | 0 |
Adachi et al. [55] | 2019 | MCB | 7 | 9 | 0.86 | 0.89 | 0 |
Nakano et al. [69] | 2019 | MCB | 18 | 27 | 0.72 | 0.81 | 4.4 |
Kobara et al. [54] | 2017 | STB | 29 | 14 | 1 | 1 | 0 |
Park et al. [57] | 2019 | unroofing biopsy | 15 | 13 | 0.80 | 0.77 | 0 |
Abad-Belando et al. [70] | 2018 | deep biopsy | 16 | 16 | 0.94 | 1 | 9.4 |
MIAB: mucosal incision-assisted biopsy; MCB: mucosal cutting biopsy; STB: submucosal tunneling biopsy.